The effect of canagliflozin on body fat volume
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000021327
- Lead Sponsor
- Department of Cardiovascular Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Hypersensitivity to canagliflozin, Complicated with sever ketoacidosis, diabetic coma, Type 1 diabetes Complicated with severe infection, sever trauma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Epicardial Adipose Tissue Thickness,HbA1c6 month after the treatment
- Secondary Outcome Measures
Name Time Method body weight, voluem of visceral fat, subcutaneous fat, skeletal muscle